First results are given from the comparison of experimental values and model calculations on accelerator-produced high specific activity radionuclides in no-carrier-added (NCA) form. The relevant radioisotopes are: Cu-64, produced by Zn-nat(d,alfaxn) and Zn-ant(d,2p) reactions, for simultaneous positron/negatron metabolic radiotherapy and PET imaging; 66Ga high-energy positron emitter (4.2MeV), produced by Zn-nat(d,xn) reactions, for metabolic radiotherapy and for PET; 186gRe, produced by 186W(p,n) and 186W(d,2n) reactions, for negatron (1.1MeV) metabolic radiotherapy; At-211/Po-211, produced by Bi-209(alfa,2n) reaction (with spike of gamma emitter At-210 produced by Bi-209(alfa,3n) reaction) and Ac-225/Bi-213/Po-213, produced by Ra-226(p,2n) reaction, both for high-LET radiotherapy.
Experimental results and model calculations of excitation functions relevant to the production of specific radioisotopes for metabolic radiotherapy and for pet
2004-10-01
Abstract
First results are given from the comparison of experimental values and model calculations on accelerator-produced high specific activity radionuclides in no-carrier-added (NCA) form. The relevant radioisotopes are: Cu-64, produced by Zn-nat(d,alfaxn) and Zn-ant(d,2p) reactions, for simultaneous positron/negatron metabolic radiotherapy and PET imaging; 66Ga high-energy positron emitter (4.2MeV), produced by Zn-nat(d,xn) reactions, for metabolic radiotherapy and for PET; 186gRe, produced by 186W(p,n) and 186W(d,2n) reactions, for negatron (1.1MeV) metabolic radiotherapy; At-211/Po-211, produced by Bi-209(alfa,2n) reaction (with spike of gamma emitter At-210 produced by Bi-209(alfa,3n) reaction) and Ac-225/Bi-213/Po-213, produced by Ra-226(p,2n) reaction, both for high-LET radiotherapy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.